Severity
Critical
FDA Drug recall · Reported March 19, 2014
Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unapproved new drug.
Ctv Best Group recalled BEST Slim, Dietary Supplement, 100% Natural Weight Loss Pill, 40 Pills per bottle, Distri… - a critical-severity action.
BEST Slim, Dietary Supplement, 100% Natural Weight Loss Pill, 40 Pills per bottle, Distri… was recalled by Ctv Best Group in March 19, 2014. Reason: Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unappro…. Check the official notice for the remedy. Verify recall #D-1154-2014 with the FDA Drug before acting.
The recall
Ctv Best Group issued this critical-severity FDA Drug recall-Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unappro….
Sourced from official FDA Drug enforcement records. Verify recall #D-1154-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1154-2014) was formally reported on March 19, 2014, with the manufacturer initiating the action on August 1, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Ctv Best Group is listed as the recalling firm, operating out of Duluth, GA. Federal records list the affected scope as 593 bottles.
The documented reason for this recall is: Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unapproved new drug. Distribution data in the federal record shows the product reached: Nationwide and Australia, Canada.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
593 bottles
Related Recalls
6
5 from same agency
BEST Slim, Dietary Supplement, 100% Natural Weight Loss Pill, 40 Pills per bottle, Distributed by CTV Best Group Inc., P.O. Box 956452, Duluth, GA 30095.
Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unapproved new drug.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-1154-2014 |
| Date reported | March 19, 2014 |
| Date initiated | August 1, 2013 |
| Recalling firm | Ctv Best Group |
| Firm location | Duluth, GA |
| Affected scope | 593 bottles |
| Distribution | Nationwide and Australia, Canada. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported March 19, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.